Home > Insider Trading > Filing (0001567619-22-000277)

Filing Details

Accession Number:: 0001567619-22-000277
Form Type:: 4
Zero Holdings:: No
Publication Time:: 2022-01-04 17:02:09
Reporting Period:: 2021-12-30

Accepted Time:: 2022-01-04 17:02:09
SEC Url:: Form 4 Filing

Issuer

Cik	Name	Symbol	Sector (SIC)	IRS No
1439725	Biodesix Inc	BDSX	()	4

Insiders

Cik	Name	Reported Address	Insider Title	Director	Officer	Large Shareholder	Other
1377832	Matthew Strobeck	2970 Wilderness Place Suite 100 Boulder CO 80301		Yes	No	No	No

Reported Non-Derivative Transactions

Show Other Fields >>

Sec. Name	Acquisiton - Disposition	Date	Amount	Price	Remaning Holdings	Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
Common Stock	Acquisiton	2021-12-30	138,700	$4.35	211,200	No	4	P	Indirect	By Birchview Fund LLC
Common Stock	Acquisiton	2021-12-30	9,100	$4.35	19,933	No	4	P	Indirect	By Birchview Capital Separately Managed Account

Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
No	4	P	Indirect	By Birchview Fund LLC
No	4	P	Indirect	By Birchview Capital Separately Managed Account

Reported Non-Derivative Holdings

Sec. Name	Remaning Holdings	Nature of Ownership	Explanation
Common Stock	966,883	Direct
Common Stock	3,518	Indirect	By UGMA Account
Common Stock	3,518	Indirect	By UGMA Account
Common Stock	3,518	Indirect	By UGMA Account
Common Stock	3,518	Indirect	By UGMA Account
Common Stock	40,665	Indirect	By Clajer Capital LLC

Footnotes

The reporting person has sole voting and dispositive power with respect to shares held by Birchview Fund, LLC and the Birchview Capital Separately Managed Account in his capacity as Managers of such entities. The shares reported herein as held by Birchview Fund, LLC and the shares reported held by Birchview Capital Separately Managed Account were always held for each respective account, but were inadvertently reported as all being held for Birchview Fund, LLC in the Form 4 filed on November 3, 2020. The reporting person disclaims beneficial ownership of these shares except to the extent of his pecuniary interest therein, and the inclusion of these shares in this report shall not be deemed an admission of beneficial ownership of all of the reported shares for purposes of Section 16 or for any other purpose.
The reporting person disclaims beneficial ownership of these shares except to the extent of his pecuniary interest therein, and the inclusion of these shares in this report shall not be deemed an admission of beneficial ownership of all of the reported shares for purposes of Section 16 or for any other purpose.
The reporting person is an affiliate of Clajer Capital LLC. The reporting person disclaims beneficial ownership of these shares except to the extent of his pecuniary interest therein, and the inclusion of these shares in this report shall not be deemed an admission of beneficial ownership of all of the reported shares for purposes of Section 16 or for any other purpose.
In the Form 4 filed by the reporting person on November 3, 2020, and each subsequent Form 4, the Amount of Securities Beneficially Owned reported in Table I as directly held was inadvertently overstated by 92 shares. This Form 4 corrects, in Table I, the Amount of Securities Beneficially Owned directly by the reporting person.
In the Form 4 filed by the reporting person on November 3, 2020, and each subsequent Form 4, the Amount of Securities Beneficially Owned reported in Table I as held by each UGMA Account was inadvertently overstated by 4 shares. This Form 4 corrects, in Table I, the Amount of Securities Beneficially Owned by each UGMA Account.
In the Form 4 filed by the reporting person on November 3, 2020, and each subsequent Form 4, the Amount of Securities Beneficially Owned reported in Table I as held by Clajer Capital LLC was inadvertently overstated by 22 shares. This Form 4 corrects, in Table I, the Amount of Securities Beneficially Owned by Clajer Capital LLC.